SNN Smith & Nephew Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: SNN
  4. Earnings
Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 79

EPS in 2026 (TTM): $1.48

Last Report Period Date: Jun 27, 2026

Currently, SNN's trailing twelve months (TTM) EPS stands at $1.48, according to the most recent financial reports. In 2025, SNN reported a per-share earnings of $1.44, which represents an increase compared to the EPS of $0.94 recorded in 2024.

SNN earnings history

Historical annual and quarterly earnings per share (EPS) data for Smith & Nephew
EPS (TTM)
$1.48

In 2025, Smith & Nephew's EPS was $1.44, an increase of 53.2% from $0.94 in 2024. The trailing twelve months (TTM) EPS as of June 2026 is $1.48. In 2024, the annual EPS was $0.94, showing an increase of 56.7% compared to 2023.

SNN EPS vs price chart

SNN EPS growth history

Earnings per share growth rates over time
EPS growth YoY
53.2%
EPS growth 3Y avg
41.3%
EPS growth 5Y avg
6.9%

Looking at a longer timeframe, the company recorded an average EPS annual growth rate of 41.3% per year for the last 3 years. Over the last five years, the company had an average annual EPS growth of 6.9%. A ten-year view shows that SNN has seen an average earnings per share growth of 4.6% per year.

SNN Earnings Waterfall

Breakdown of revenue, profit and net income for Smith & Nephew

SNN Earnings vs Peers

What are the earnings of SNN compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
SNN Smith & Nephew plc 20.14 53.2% 41.3% 6.9%
BSX Boston Scientific Corp 20.82 55.6% 63.3% N/A
MDT Medtronic Plc 24.34 3.3% 9.8% 6.9%
ZBH Zimmer Biomet Holdings Inc 24.37 -20% 47.9% N/A
JNJ Johnson & Johnson 29.82 90.6% 17.7% 14.8%
SYK Stryker Corp 34.83 8% 10.9% 14.8%
ABT Abbott Laboratories 35.89 -51.4% -1.8% 8.2%
ISRG Intuitive Surgical Inc 44.68 22.3% 29.1% 21.5%
EW Edwards Lifesciences Corp 52.64 -73.6% -9.2% 6.9%
BDX Becton Dickinson & Company 55.24 -0.9% -0.6% 16.2%
BAX Baxter International Inc N/A -47.2% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.